Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03424343
Other study ID # S60535
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date August 28, 2018
Est. completion date March 2024

Study information

Verified date February 2024
Source KU Leuven
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The study investigators plan to conduct a longitudinal questionnaire study in adolescents and emerging adults (14-25 years of age at the start of the study) who survived childhood cancer to chart their identity development and broader social functioning. Additionally, the functioning of these survivors will be related to the functioning of their parents and siblings. The investigators shall focus especially on the current experience and impact of the earlier cancer experience. They will investigate to what extent the experience of a life-threatening disease has an effect on the daily life of survivors and over time and how the survivors develop through the course of adolescence and emerging adulthood on the psychosocial level. The formation of an adult identity is a very challenging task during adolescence and the way to adulthood and the fact that these youth had cancer during their childhood may especially complicate this process of identity formation. Furthermore, both parental and sibling functioning will be taken into account, which will allow us to examine inter-generational mechanisms (thus parental functioning that possibly impacts youth functioning and vice versa) and sibling functioning in these families. To investigate the latter, at each timepoint of the longitudinal study a sibling between 14 and 25 years of age at the start of the study will be included (if there is more than one sibling in a family, ideally the sibling who is closest in age will be the one who participates in the study). Moreover, a community sample that is matched on age and sex with the survivor of pediatric cancer will be assessed. This will allow the investigators to make well-founded comparisons regarding identity development and broader psychosocial functioning.


Description:

In the present longitudinal study, four main research questions will be investigated. 1. How does identity develop in cancer survivors? Based on previous findings from studies in identity development, it seems that young adults with a chronic disease like type 1 diabetes show less exploration or consider less identity possibilities from which they can choose, e.g. they dwell less upon the choice of education. Does this finding also apply to survivors of childhood cancer or are these youth more similar to a community sample? This research question may provide an answer to the question whether or not there is a continued (psychological) impact of childhood cancer on the later identity development of survivors. For this purpose the investigators shall make use of an identity model which was developed at their research department and which has gained much international research attention. In addition, the investigators want to look at illness-identity, which comprises the amount to which the earlier cancer experience is integrated into one's identity. Does the youngster feel still engulfed by the earlier cancer experience, or has he/she integrated this experience as part of his/her self-concept? Or does the youngster feel even enriched by the earlier cancer experience, thus did he/she end up even stronger through the experience? 2. How do survivors of pediatric cancer and/or their parents function on the psychological level, more specific on the level of life satisfaction and depressive symptoms, and what is the role of identity and personality variables herein? This question examines, among other factors, concepts like benefit-finding, post-traumatic growth, resilience,... Thereby it would be interesting to examine whether different subgroups can be identified, for example, which groups of persons display less adaptive functioning and why? 3. Are there certain parenting dimensions (e.g. overprotection, responsiveness, psychological control,...) which are more prevalent in families that were confronted with pediatric cancer and are these dimensions differently related to the psychosocial adaptation of survivors? Does this relate to certain aspects of survivor functioning, like depressive symptoms and quality of life? Thereby, transactional processes between survivor and parental functioning will be investigated, e.g. does identity development of survivors have an impact on parental well-being, and has parental well-being in turn an impact on survivor functioning? Taken together, the investigators want to investigate to what extent these contextual variables determine the functioning of adolescents and emerging adults. 4. What is the impact for siblings of cancer survivors? How do they go through their identity process? Do they experience the same parenting as the survivors experience themselves? E.g if survivors would experience more parental overprotection, would siblings experience overprotection to the same extent?


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 126
Est. completion date March 2024
Est. primary completion date March 2024
Accepts healthy volunteers
Gender All
Age group 14 Years to 25 Years
Eligibility Inclusion Criteria: - Survivors of childhood leukemia/lymphoma, solid tumors, and brain tumors, of whom the treatment has ended. - 14-25 years at the start of the study - Treated at the department of pediatric oncology at University Hospital Leuven, Belgium. - Sufficient knowledge of Dutch Exclusion Criteria: - Mental retardation which hinders completion of the questionnaire bundle - Younger than 14 year and older than 25 year - Physically incapable to complete the questionnaire bundle - Insufficient knowledge of Dutch - Contact information is not available

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Questionnaire bundle
Questionnaires on identity formation and psychosocial functioning, assessed and reported at baseline, one year later, two years later, and five years later.
Obtaining information from survivors' medical file
After obtaining informed consent, we will access the medical file of participants to obtain information on the diagnosis, time of diagnosis, treatment duration, type of treatment, and relapse (when applicable).

Locations

Country Name City State
Belgium Gasthuisberg Leuven Vlaams-Brabant

Sponsors (3)

Lead Sponsor Collaborator
KU Leuven Research Foundation Flanders, Universitaire Ziekenhuizen KU Leuven

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Dimensions of Identity Development Dimensions of Identity Development Scale (DIDS); dimensions: commitment making (range: 5 - 25), Identification with Commitment (range: 5 - 25), Exploration in Breadth (rang: 5 - 25), Exploration in Depth (range: 5 - 25), Ruminative Exploration (range: 5 - 25); for each dimension, a higher score indicates more identification with the dimension Assessed and reported at baseline, one year later, two years later, and five years later
Primary Change in Identity from an Eriksonian Perspective Erikson Psychosocial Stage Inventory (EPSI); subscales: Synthesis (range: 5 - 30), Confusion (range: 5 - 30); for each scale, higher scores indicate more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Primary Change in Illness Centrality Illness Centrality; total scale range: 0 - 4; A higher score indicates more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Primary Change in Self-Identity after Cancer Self-Identity after Cancer; dimensions: victim of cancer (range: 1 - 5), cancer patient (range: 1 - 5), person who had cancer (range: 1 - 5), survivor (range: 1 - 5); for each dimension, a higher score indicates more identification with the dimension Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Post-Traumatic Stress Symptoms (measured in survivors) Children's Revised Impact of Event Scale (CRIES-13); total scale range: 0 - 65; Higher scores indicate more sensitivity for PTSD; A score higher than 30 possibly indicates the presence of PTSD; subscales: Intrusion (range: 0 - 20), Avoidance (range: 0 - 20), Arousal (range: 0 - 25); Higher scores indicate more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Illness-related Benefit Finding (measured in survivors) Benefit scale from the Benefit and Burden Scale (BBSC); total scale range: 10 - 50; A higher score indicates more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Depressive Symptoms (measured in survivors, siblings, and parents) Center for Epidemiologic Studies Depression (CES-D-12); total scale range: 0 - 36; a higher score indicates the presence of more depressive symptoms Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Cancer-related Worries (measured in survivors and parents) Cancer Related Worries Scale; total scale range: 4 - 20; A higher score indicates the presence of more cancer-related worries Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Global Life Satisfaction (measured in survivors, siblings and parents) Satisfaction with Life Scale (SWLS); total scale range: 5 - 35; A higher score indicates more satisfaction with life Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Bodily Functioning (measured in survivors) Short Form 36, physical subscale (SF-36); total scale range: 10 - 30: A higher score indicates worse bodily functioning Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Self-Esteem (measured in survivors, siblings, and parents) Rosenberg Self-Esteem Scale (RSES); total scale range: 10 - 40: A higher score indicates higher self-esteem Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Resilience (measured in survivors and parents) Brief Resilience Scale (BRS); total scale range: 6 - 30; A higher score corresponds to being more resilient Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Personality (measured in survivors and siblings) Big Five Inventory 10 (BFI-10); subscales: Extraversion (range: 2 - 10), Agreeableness (range: 2 - 10), Conscientiousness (range: 2 - 10), Neuroticism (range: 2 - 10), Openness (range: 2 - 10); for each scale, a higher score indicates more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Self-Harm (measured in survivors) Based on Goossens et al., 2013: Health risk behaviors in adolescents and emerging adults with congenital heart disease: psychometric properties of the Health Behavior Scale-Congenital Heart Disease Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Perception of Control (measured in survivors, siblings, and parents) Multidimensional Health Locus of Control Scale (MHLCS): subscales: Internal Health Locus of Control (range 6 - 36), Powerful Others Health Locus of Control (range 6 - 36), Chance Health Locus of Control (range: 6 - 36); for each scale, a higher score indicates more identification with the scale Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Social Support (measured in survivors and siblings) Multidimensional Scale of Perceived Social Support (MSPSS); subscales: support from special someone (range: 4 - 28), support from family (range: 4 - 28), support from friends (range: 4 - 28); for each subscale, a higher score indicates more support Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Contact with Peer Survivors (measured in survivors) Self-constructed questionnaire Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Parental Behavioral Control (measured in survivors, parents, and siblings) Based on the 8-item Parental Expectations for Behavior Scale and the 8-item Parental Monitoring of Behavior Scale uit de 'Parental Regulation Scale - Youth Self-Report' (PRS -YSR; Barber, 2002); Behavioral Control; total scale range: 7 - 35; A higher score indicates more parental behavioral control Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Parental Responsiveness (measured in survivors, parents, and siblings) Child Report of Parent Behavior Inventory (CRPBI; Schaefer, 1965; Schludermann & Schludermann, 1988); Responsiveness; total scale range: 7 - 35; A higher score indicates more parental responsiveness Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Parental Overprotection (measured in survivors, parents, and siblings) based on Dutch Multidimensional Overprotective Parenting Scale, Kins & Soenens, 2013; Overprotection / anxious parenting; Overprotection; total scale range: 8 - 40; A higher score indicates more parental overprotection Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Parental Psychological Control (measured in survivors, parents, and siblings) 8-item Psychological Control Scale-Youth Self-Report ( Barber, 1996); Psychological Control; total scale range: 8 - 40; A higher score indicates more parental psychological control Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Illness Intrusiveness (measured in parents) Illness Intrusiveness Questionnaire Parent Report (IIQ-Parent Report); total scale range: 13 - 91; A higher score indicates more illness intrusiveness Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Parental competence (measured in parents) Parenting Stress Index - Sense of Competence Scale; total scale range: 13 - 78; A higher score indicates a lower sense of parental competence Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Role Restriction (measured in parents) Parental Burden Questionnaire, subscale role restriction; total scale range: 6 - 24; A higher score indicates a greater sense of role restriction Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Relationship Quality (measured in parents) Family Functioning Questionnaire, subscale parental relationship quality; total scale range: 5 - 20; A higher score indicates a greater sense of partner relationship quality Assessed and reported at baseline, one year later, two years later, and five years later
Secondary Change in Benefit Finding (measured in parents) Benefit Finding Scale; total scale range: 15 - 105; A higher score indicates more benefit finding Assessed and reported at baseline, one year later, two years later, and five years later
See also
  Status Clinical Trial Phase
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Not yet recruiting NCT06335745 - PediCARE Health Equity Intervention in High-Risk Neuroblastoma N/A
Withdrawn NCT04719416 - Relaxation Therapy in Pediatric Oncology N/A
Completed NCT01645436 - Physical Activity in Pediatric Cancer (PAPEC) N/A
Completed NCT04409301 - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation N/A
Completed NCT04914702 - Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer.
Recruiting NCT05425043 - Granulocyte Transfusions After Umbilical Cord Blood Transplant N/A
Recruiting NCT05071859 - Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
Recruiting NCT03241251 - Screening for Psychosocial Risk in Flemish Families of a Child With Cancer
Recruiting NCT05384288 - Response to Influenza Vaccination in Pediatric Oncology Patients
Completed NCT04586491 - The Effect of Oral Care Protocol on Prevention of Oral Mucositis in Pediatric Cancer Patients N/A
Recruiting NCT05569512 - Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML Phase 1/Phase 2
Enrolling by invitation NCT05294380 - Determination of Sarcopenia Risk and Related Factors in Pediatric Oncological Patients
Completed NCT02665819 - Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility. N/A
Completed NCT02675166 - Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes
Not yet recruiting NCT05454163 - Post-radiotherapy Rhinosinusitis in Children
Terminated NCT02536183 - A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Phase 1
Withdrawn NCT01828502 - Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer Phase 2
Completed NCT02032121 - Vascular Endothelial Inflammation and Dysfunction in Pediatric Long-term Cancer Survivors N/A
Completed NCT03964259 - Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia Phase 1